U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938866) titled 'Genomic Predictors of Response to CAR-T and BiTE Therapies in B-cell Non-Hodgkin Lymphomas' on Nov. 10.

Brief Summary: The purpose of this prospective, non-therapeutic study is to evaluate molecular and clinical factors associated with clinical outcomes following CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy and bispecific T-cell engager (BiTE) therapies in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (R/R NHL).

Study Start Date: Nov. 15

Study Type: OBSERVATIONAL

Condition: Non-Hodgkin Lymphoma Refractory/ Relapsed

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Duke University

Published b...